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Background: We assessed the hypothesis that EVT was safe and good result compared with bypass surgery. The purpose of this study was to 
evaluate long-term outcomes of EVT and bypass surgery in the claudicator with complex lesions.
methods: We pooled data from patients enrolled in RECANALISE (REtrospective Comparative ANAlysis of the revascuLarization method for 
Infrainguinal artery disease, surgical reconstraction and Endovascular treatment) registry, which is a multicenter registry in Japan. Of 1165 patients 
underwent revascularization, 696 patients (mean follow-up 40±24 month) were treated because of intermittent claudication. After TASCII-A/B 
patients were excluded, 313 lesions only with femoropopliteal lesion (EVT vs. bypass =202 vs. 111) were analyzed by Kaplan-Meier methods and 
compared by the log rank test.
results: Overall complication rate was 3.5% and 14.4% in EVT and bypass surgery group (p<0.01). 1 and 5 years primary patencies were 82% and 
74% in bypass surgery group; 68% and 51% in EVT group. Although bypass surgery group had higher primary patency rate than EVT group by the log 
rank test (p<0.01), secondary patency rates were not different significantly between EVT and bypass surgery group.
conclusions: In conclusion, though bypass surgery is feasible treatment for the claudicator with TASC-C/D femoropoplieteal desease, EVT is also 
good option by the reason of lower complication rate and good secondary patency rate.
 
